RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 100-110
  • U.S. doctor was treated with experimental Ebola drug TKM-Ebola

    U.S. doctor was treated with experimental Ebola drug TKM-Ebola
    An American doctor who is recovering from Ebola at a Nebraska hospital got an experimental Canadian drug as part of his treatment, hospital officials disclosed this week. Dr. Rick Sacra started receiving TKM-Ebola, manufactured by Canadian drug firmĀ ...
  • Allergan likely to lose bid to stop takeover by Valeant, analyst says

    Allergan likely to lose bid to stop takeover by Valeant, analyst says
    Botox maker Allergan Inc. of Irvine appears increasingly likely to be acquired by a Canadian rival, an analyst said Tuesday. Valeant Pharmaceuticals International Inc. has been working for five months to acquire Allergan and its coveted lineup of beauty...
  • Company denies rat poison in pills linked to India sterilization deaths

    Company denies rat poison in pills linked to India sterilization deaths
    The company at the center of a probe into why more than a dozen women died after being sterilized in India has denied that the antibiotic tablets it manufactured were contaminated with a chemical compound commonly found in rat poison. Preliminary tests...
  • Ingredion predicts $8 billion in sales by 2019

     Ingredion predicts $8 billion in sales by 2019
    Ingredion said Tuesday its annual sales should hit $8 billion by 2019, up from $6.33 billion last year, as the ingredients-maker pushes to notch more sales from fast-growing specialty products and international markets. The announcement comes weeks after...
  • The Medicine Cabinet-Ask the Harvard Experts: With even some generics rising in price, explore ways to cut your drug costs

    Q: Recently, my doctor prescribed a 10-day course of doxycycline. I always ask for a generic since I need to pay full price. I was shocked when the pharmacist said it would be almost $65. I took this medication three years ago and I think it cost me...
  • Generic drug prices skyrocket in past year

     Generic drug prices skyrocket in past year
    After calling for a routine prescription refill, Craig Elliott got a rude shock: His bill was going up fivefold. The 44-year-old piano tuner and guitar instructor from Elgin, who has health insurance, used to pay $20 for a three-month supply of his...
  • Though cheered by Wall Street, most mergers don't work out for buyers

    — Wall Street's big business — helping companies buy other companies — is hotter than it's been in years. When pharmaceuticals giant Actavis said it was buying Allergan Inc. in Irvine and Halliburton said it would take over rival oil-...
  • Sentara invests in pharmacy management company

    Sentara invests in pharmacy management company
    After several months as a customer of NuScriptRX, a 4-year-old pharmacy management company based in Nashville, Tenn., Sentara Healthcare has purchased a 12 percent share in the company. The company has developed a fully automated on-site medication...
  • Baxter seeks OK to sell new hemophilia drug

    Baxter International on Monday said it had submitted an application to the Food and Drug Administration for the approval of a key hemophilia drug. The drug, BAX 855, is an extended-release version of its flagship hemophilia drug Advate, which is sold...
  • Raw deal for AbbVie, but does anyone care?

    Raw deal for AbbVie, but does anyone care?
    AbbVie got hosed on its aborted Shire deal. Let's get that up top. It's also very hard to feel sorry for it. Sure, the North Chicago-based pharmaceutical business failed to score Adderall and the Irish outfit behind it. You can make all the cracks you...
  • Valeant says it's willing to boost offer for Botox maker Allergan

    Valeant says it's willing to boost offer for Botox maker Allergan
    A Canadian company said it is willing to significantly increase its offer for Botox maker Allergan Inc., the latest chapter in the attempted takeover of the Irvine company. Valeant Pharmaceuticals International Inc. said it would be willing to pay up to...